2 ms·
Regulations suffocating progress is a real problem. It's why, aside from ASML and Spotify, the EU's tech industry has stagnated for 20 years. The FDA should su
by xvector 3y ago
Regulations suffocating progress is a real problem. It's why, aside from ASML and Spotify, the EU's tech industry has stagnated for 20 years.
The FDA should subsidize safety studies for drugs like this. This would actually make it more likely to get useful, functional drugs in the hands of Americans more quickly, ie the whole point of this article.
- pkaye 3y agoIts not the safety studies. I'm sure the safety studies were done in other countries so they can submit it in the US. But if the company claims some beneficial properties to your body then its considered a drug and they need to show efficacy. But if they didn't advertise Novamin as an active ingredient they could sell it in the US but then they can't claim the benefits of that ingredient. I'm not sure how in the EU they can claim benefits without trials.